*De novo*-designed proteins are useful tools for exploring principles of protein folding, assembly, and biochemical functions that build on structure--function and sequence diversity landscapes distinct from those of natural protein scaffolds.^[@ref1]−[@ref3]^ Self-assembling tetrahelical bundles,^[@ref4]−[@ref10]^ created by binary patterning of hydrophobic and hydrophilic residues with high α-helical propensity,^[@ref11]^ comprise the best-established class of *de novo*-designed scaffolds. They provide stable frames for binding cofactors, as protein maquettes^[@ref5]−[@ref7],[@ref12]^ for rationally engineering artificial holoproteins in which the cofactor-interacting contributions of individual residues are largely isolated from one another ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a).

![Engineering *de novo*-designed proteins to stabilize biliverdin. (a) Self-assembling single-chain tetrahelical bundles created by binary patterning of hydrophobic and hydrophobic residues with a high α-helix formation propensity, described by the helical wheel. (b) Strategy for stabilizing biliverdin within the core. (c) Holoprotein stepwise construction.](bi-2018-01076y_0001){#fig1}

Previously reported maquette holoproteins incorporated rigid, planar cofactors such as hemes, chlorins, porphyrins, and flavins. Recently, we reported that they also bind flexible bilins or linear tetrapyrroles and identified determinants for autocatalytic ligation of phycocyanobilin (PCB), namely, a free cysteine and the stabilization of the bilin propionates.^[@ref6]^

Here, we report the rational construction of compact *de novo*-designed proteins that bind biliverdin (BV), the optically active cofactor in bacteriophytochromes (Bph) and Bph-derived protein tools.^[@ref13]−[@ref16]^ Energy minimization modeling in Rosetta^[@ref8],[@ref9],[@ref17],[@ref18]^ informed the placement of residues for stabilizing BV, which increased its far-red fluorescence. Despite lacking sequence or structural homology to natural biological fluorochromes, fluorescent bili-proteins were successfully forward-engineered with molecular weights as small as 10 kDa or half that of a minimal fluorescent domain engineered from a Bph.^[@ref14]^

Results and Discussion {#sec2}
======================

Rational Design and Construction Strategy {#sec2.1}
-----------------------------------------

Fluorescent proteins (FPs) have been engineered by directed evolution of Bph,^[@ref13]−[@ref16]^ phytochromes (Phys),^[@ref19],[@ref20]^ allophycocyanins^[@ref21],[@ref22]^ (APs), and fatty acid-binding muscle proteins.^[@ref23]^ These engineered proteins are generally rigidified (i) to stabilize the cofactor in a fluorescent conformation, (ii) to limit access of the solvent and oxygen to the cofactor, and (iii) to prevent protein structural rearrangements intrinsic to their signaling roles.

Structural insights from Bph- and Phy-derived FPs^[@ref15],[@ref16],[@ref19]^ led to a design strategy for stabilizing the bilin by hydrogen bonding to the BV propionates and A-ring and adding hydrophobic core bulk around the D-ring ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). In our rational construction strategy ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c), we first experimentally identified a suitable cofactor attachment site on a scaffold, which was derived from maquettes with molten globular cores^[@ref5],[@ref24]^ that accommodate a range of cofactor types and sizes. BV-stabilizing residues were subsequently introduced stepwise to define a pocket within the apoprotein core. In the absence of a high-resolution structure for this scaffold, the binding pocket structure-function analysis was informed by energy minimization modeling using Rosetta, given its reported ability to predict helical bundle topologies and binding sites for rigid, planar cofactors.^[@ref8]−[@ref10]^

Cysteine Ligation Scanning {#sec2.2}
--------------------------

Bilin-containing holoproteins can be reconstituted *in vitro* by autocatalytic ligation of bilin to cysteine.^[@ref6],[@ref25],[@ref26]^ To identify suitable ligation positions around which to construct a binding pocket, we scanned cysteine sites for BV covalent attachment efficiency to purified apoproteins *in vitro* ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). All core residues (heptad repeat positions a and d) were leucines to limit potential contributions to bilin stabilization by structured interactions within the core.

![Cysteine scanning for biliverdin (BV) attachment. (a) Rosetta-generated Pymol model of the scaffold, with candidate attachment sites. (b) Scaffold sequence. (c) Relative BV attachment, fluorescence, and brightness summary (mean ± the standard error). Fluorescence measured at fixed holoprotein concentrations (λ~ex~ = 600 nm). Brightness calculated as absorbance × fluorescence. Abbreviations: AUC, area under the curve; Abs, absorbance; Em, emission; Q, Q-band.](bi-2018-01076y_0002){#fig2}

BV attachment levels trended with cysteine solvent exposure, where those in the solvent-exposed B-loop (S64C) or near the termini (L23C) provided good relative balances of appreciable cofactor attachment and baseline fluorescence from partitioning into the hydrophobic core ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c). In selecting construction starting points, we prioritized BV attachment efficiency given the reported challenges in the uptake of the cofactor by Bph-FPs.^[@ref13],[@ref16]^ Subsequent engineering proceeded faster with the loop-bound S64C maquette, the starting point of proteins hereafter. Rosetta modeling suggested a favored BV placement in the core where an existing arginine (R119) and lysine (K77) of the scaffold stabilize the cofactor propionates.

Rational Cofactor Stabilization {#sec2.3}
-------------------------------

Stepwise modifications had the intended hierarchical effects of increasing the BV attachment efficiency, enhancing the fluorescence quantum yield (ϕ~F~), and sharpening absorbance Q-bands ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} and [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)), with the latter two events indicative of bilin rigidification.^[@ref26]^ The helix 4 terminus adjacent to the BV-binding cysteine (C64) was rigidified and made more hydrophobic by placing a valine (K124V) at the interfacial b-position of the last heptad repeat (build step 2). Cofactor stabilization and placement continued from the A-ring, the most constrained pyrrole from covalent attachment, by introduction of a serine (L5S) intended to hydrogen bond the A-ring nitrogen (build step 3).

![Rational engineering of a biliverdin-binding *de novo-*designed fluorescence-activating protein (dFP). (a) Homology-based contact schematic (left) for BV stabilization (black, side chains; green, BV) and Pymol visualization (right) of the BV-binding site in the Rosetta-modeled core. (b) Sequence alignment of the build series (yellow, mutated residues). The E66R mutation was introduced with the S64C mutation based on "CXR" motifs of natural bili-proteins but did not contribute to stabilization. (c) Excitation (dashed lines; λ~em~ \> 715 nm) and emission spectra (solid lines; λ~ex~ = 600 nm) of the stepwise construction. (d) Photophysical summary. Abbreviations: QY, relative quantum yield vs Cy5; ε, extinction coefficient. An asterisk indicates a value below the quantification limit. In panels b--d, build step 4 = dFP.](bi-2018-01076y_0003){#fig3}

The cofactor B-, C-, and D-rings were further immobilized by positioning histidines (L75H and F120H) to π-stack with the pyrroles and to provide hydrophobic core bulk that restricts protein movement and core water access (build step 4), which has stabilized tetrapyrroles effectively in previous maquettes.^[@ref5],[@ref6]^ Rosetta modeling of the final product suggests S5 may further constrain the A-ring by hydrogen bonding to both the A-ring oxygen and H71 ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a).

The resultant 15 kDa monomer fluoresced modestly in the far-red spectrum (λ~ex~ = 648 nm; λ~em~ = 662 nm; ϕ~F~ = 1.58%). The quantum yield is similar to that of sandercyanin, a natural BV-binding fish pigment (ϕ~F~ = 1.6%),^[@ref27]^ and is smaller than those of Bph- and AP-derived directed evolution products (ϕ~F~ ∼ 7--18%).^[@ref13]−[@ref16],[@ref21]^ For the sake of simplicity, we hereafter call this *de novo*-designed fluorescence-activating protein ("dFP").

dFP was predominantly monomeric in analytical ultracentrifugation (AUC) assays ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)). Circular dichroism measurements confirmed the bundle helicity and showed that cofactor binding enhanced the overall protein thermal stability (*T*~m-apo~ = 44.7 °C, and *T*~m-holo~ = 50.8 °C) ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)). Mass spectrometry and zinc acetate staining of denaturing protein gels confirmed covalent bilin attachment ([Figure S3a--c](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)). Noncovalently adsorbed BV was sufficiently removed by filtration on desalting columns ([Figure S3d](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)).

Biliverdin formed a thioether bond between its vinyl group and C64, based on acidic denaturation studies in guanidinium chloride ([Figure S4a--d](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)). The dFP(C64S) mutation destabilized BV within the core, which is evident by the diminished level of uptake, Q-band absorbance, and fluorescence quantum yield (ϕ~F~ = 0.8%) ([Figure S4b](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)). BV was stripped from dFP(C64S) upon denaturation and column filtration and, thus, noncovalently bound to this mutant. Similarly, cysteine-containing dFP bound less mesobiliverdin (meso-BV), which differs from BV by its reduced vinyl side chains (to ethyl), and was stripped from the holoprotein upon denaturation ([Figure S4c](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)).

Biliverdin of denatured dFP did not appreciably photoconvert upon stimulation (λ = 610 ± 5 or \>650 nm) based on the difference spectrum ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)), suggesting that its D-ring adopts a 15*Z* configuration^[@ref28]^ as designed ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a and [3](#fig3){ref-type="fig"}b) and not the photoconverting 15*E* configuration.^[@ref28]^ A future high-resolution structure would greatly inform dFP structure-function analysis.

Miniature 10 kDa Bili-Protein ("mini") {#sec2.4}
--------------------------------------

The 15 kDa dFP contains extraneous heptad repeats for cofactor binding and stabilization needs. We sought to engineer a miniature dFP (hereafter called "dFP-mini" or "mini") ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a,b) by truncating the scaffold down to where homology modeling predicts all BV pyrroles remain solvent-shielded. To preserve bundle stability, truncation began after the hydrophobic caps at the helical termini closest to the D-ring. Loops 1 and 3 were also shortened.

![Miniature 10 kDa *de novo*-designed bili-protein (mini). (a) Pymol renders the BV-binding site in Rosetta-modeled full-length and mini dFPs. (b) Sequence alignment. (c) Mini excitation (dashed line; λ~em~ \> 715 nm) and emission (solid line; λ~ex~ = 600 nm) spectra. ϕ~F~ = 1.48%. ε = 16209 cm^--1^ M^--1^; 16.44% attachment efficiency.](bi-2018-01076y_0004){#fig4}

A stable 10 kDa mini was formed with helices that extend a half-heptad repeat beyond the furthest modeled D-ring contact residue. Shorter proteins terminating at the final hypothetical contact were unstable. dFP-mini had photophysical properties nearly identical to those of full-length dFP ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}c). Likewise, the mini forms a thioether bond with the BV vinyl group ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)), and the cofactor D-ring adopts a 15*Z* orientation ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf)).

The mini is approximately one-third the size of GFP (27 kDa) and Bph-derived FPs (30--35 kDa) and half that of a minimal domain engineered from a Bph (18 kDa).^[@ref14]^ The facile truncation and relative compactness reflect the structural simplicity of the *de novo*-designed scaffold. Other than three interhelical loops and hydrophobic caps, the mini lacks accessory structural elements beyond the cofactor-binding pocket itself.

Compact protein fluorochromes are advantageous in molecular sensors because they shorten Förster distances and limit potential interference with the activity of fusion partners. Because BV is endogenous to eukaryotes, this study is a valuable step toward fully genetically encoded and compact *de novo*-designed reporters, with the primary next steps being increasing the quantum yield and bilin uptake for robust performance.

The uptake here reflects an *in vitro* autocatalytic attachment efficiency, without an evolutionarily conserved bilin lyase domain (BLD)^[@ref25],[@ref26]^ or accessory bilin lyase.^[@ref29]^ Analogous efficiencies of Bph-derived FPs (before separating apoprotein from holoprotein) are largely unreported. BV likely attaches to the *de novo*-designed scaffold by partitioning into the core and stabilizing within the binding pocket before thioether formation (as described for phytochromes^[@ref25],[@ref30]^), given that cysteine-to-serine mutations only partially decrease the level of holoprotein formation and that attachment efficiency trended with quantum yield. We anticipate that improved cofactor stabilization will enhance thioether formation and consequent fluorescence properties.

These enhancements may result from complementary directed evolution approaches and/or new computational design tools, including a recently reported "rotamer interaction field" (RIF) algorithm that decouples ligand-docking optimization from overall backbone optimization in Rosetta.^[@ref18]^ This algorithm yielded a *de novo*-designed β-barrel^[@ref18]^ that binds exogenously supplied DFHBI (chromophore of GFP) and fluoresces with a quantum yield (ϕ~F~ = 2%) similar to that described above.

To summarize, we rationally constructed compact *de novo*-designed proteins that covalently bound biliverdin and stabilized it in a fluorescent conformer. In keeping with the tenets of synthetic biology and protein design, we built them from the bottom up from first principles rather than from the top down using natural protein starting points.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.biochem.8b01076](http://pubs.acs.org/doi/abs/10.1021/acs.biochem.8b01076).Materials and Methods, cofactor rigidification and scaffold stabilization by holoprotein formation (Figure S1), and covalent attachment of BV (Figure S2) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.8b01076/suppl_file/bi8b01076_si_001.pdf))
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